WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010151697) METHOD FOR TREATING A PATIENT IN NEED OF ASPIRIN THERAPY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/151697    International Application No.:    PCT/US2010/039864
Publication Date: 29.12.2010 International Filing Date: 24.06.2010
IPC:
A01N 43/40 (2006.01), A61K 31/44 (2006.01)
Applicants: POZEN INC. [US/US]; 1414 Raleigh Road, Suite 400 Chapel Hill, NC 27517 (US) (For All Designated States Except US).
PLACHETKA, John, R. [US/US]; (US) (For US Only)
Inventors: PLACHETKA, John, R.; (US)
Agent: Steven L. Highlander; FULBRIGHT & JAWORSKI, L.L.P. 600 Congress Avenue, Suite 2400 Austin, Texas 78701 (US)
Priority Data:
61/248,755 05.10.2009 US
61/220,483 25.06.2009 US
Title (EN) METHOD FOR TREATING A PATIENT IN NEED OF ASPIRIN THERAPY
(FR) PROCÉDÉ DE TRAITEMENT D'UN PATIENT NÉCESSITANT UNE THÉRAPIE À L'ASPIRINE
Abstract: front page image
(EN)The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to the patient in need thereof a pharmaceutical composition in unit dosage form comprising aspirin, or a pharmaceutically acceptable salt thereof, and an acid inhibitor to the at risk patient and thereby decreasing the patient's risk of developing an ulcer.
(FR)La présente invention concerne un procédé de traitement d'une maladie ou d'une affection chez un patient présentant un risque de développement d'un ulcère associé à un AINS par administration au patient présentant ce risque le nécessitant d'une composition pharmaceutique sous forme posologique unitaire comprenant de l'aspirine ou l'un de ses sels pharmaceutiquement acceptables, et un inhibiteur d'acide, en réduisant ainsi le risque pour le patient de développer un ulcère.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)